WUXIUP

Serial Number 88958370
Registration 6503415
700

Registration Progress

Application Filed
Jun 10, 2020
Under Examination
Mar 23, 2021
Approved for Publication
Jan 26, 2021
Published for Opposition
Jan 26, 2021
Registered
Sep 28, 2021

Trademark Image

WUXIUP

Basic Information

Serial Number
88958370
Registration Number
6503415
Filing Date
June 10, 2020
Registration Date
September 28, 2021
Published for Opposition
January 26, 2021
Drawing Code
3000

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 28, 2021
Registration
Registered
Classes
042

Rights Holder

WUXI BIOLOGICS IRELAND LIMITED

99
Address
MULLAGHARLIN,
DUNDALK, CO LOUTH A91X56F
IE

Ownership History

WuXi Biologics Co., Ltd.

Original Applicant
99
Wuxi, Jiangsu CN

WuXi Biologics Co., Ltd.

Owner at Publication
99
Wuxi, Jiangsu CN

WuXi Biologics Co., Ltd.

Original Registrant
99
Wuxi, Jiangsu CN

WUXI BIOLOGICS IRELAND LIMITED

New Owner After Registration #1
99
DUNDALK, CO LOUTH IE

Legal Representation

Attorney
Michael T. Smith

USPTO Deadlines

Next Deadline
799 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-09-28)
Due Date
September 28, 2027
Grace Period Ends
March 28, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

34 events
Date Code Type Description Documents
Jul 26, 2023 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Sep 28, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 25, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Aug 24, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Aug 9, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 9, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jul 28, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jul 28, 2021 IUAF S USE AMENDMENT FILED Loading...
Mar 23, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 26, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 26, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 6, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 18, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 17, 2020 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Dec 17, 2020 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Dec 17, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Dec 17, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Nov 25, 2020 CNFR R FINAL REFUSAL WRITTEN Loading...
Nov 25, 2020 GNFR O FINAL REFUSAL E-MAILED Loading...
Nov 25, 2020 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Oct 21, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 20, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 20, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 25, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 25, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 25, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 13, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 26, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 26, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Aug 26, 2020 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Aug 26, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 8, 2020 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jul 7, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 13, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
product development for others; pharmaceutical drug development services; scientific research and development; pharmaceutical research; research and development of new products; Consulting services in the field of pharmaceutical technology development; biochemical research and analysis; research services for biomedical science; pharmaceutical preparations and medicines development; research and development of antibodies
First Use Anywhere: Apr 30, 2019
First Use in Commerce: Apr 30, 2019

Additional Information

Design Mark
The mark consists of the stylized wording "WUXIUP"; "WUX" is in black, "I" is blue and "UP" is yellow outlined by green; the Chinese characters above the letter "X" are black; the line underneath the wording is divided into three colors; left to right they are blue, green and yellow.
Color Claim
The color(s) blue, black, green, yellow is/are claimed as a feature of the mark.
Other
The non-Latin characters in the mark transliterate to "WUSHANG" and this translates literally to ¿supreme¿ in English. As used by the owner of the mark, the first character in the mark refers to "WuXi," and the second character means "UP" in English".

Classification

International Classes
042